An overactive bladder may be temporary or become a chronic condition. How long the symptoms last may depend on factors like the underlying cause and treatment adherence. Some conditions may cause ...

The term "voiding dysfunction" has been used to refer to urinary incontinence, urinary retention and symptoms of frequency and urgency. Overactive bladder is a specific type of voiding dysfunction ...

Discover how cold weather can trigger prostate problems in men over 60, including frequent urination, hormonal changes, and ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

While drinking adequate water remains essential for health, timing fluid intake can help manage symptoms. Reducing evening fluid consumption often improves nighttime bladder control. Some individuals ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

It's a CR Best Buy because it has a lower risk of side effects. You might not even have an overactive bladder. Symptoms that are associated with diabetes, kidney stones, multiple sclerosis ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...